Recent content by Nelson Vergel

Review of the FDA meeting: What Really Happened at the FDA Menopause Panel - Excel Male TRT Forum

https://www.excelmale.com/threads/ashley-winter-md-calls-for-label-update-on-low-dose-vaginal-estrogen.32793/

The FDA is seeking comments on backbox warning for women's hormone therapy The FDA is currently seeking public comments regarding the black box warning on women’s hormone therapy products for menopause. Here’s what you need to know: Background: Since the early 2000s, all estrogen-containing...

When it comes to peptides for muscle growth, there are several options that research has shown to be effective, though it’s important to note that peptide use should always be discussed with a healthcare provider. The most commonly researched peptides for muscle growth include: Growth Hormone...

Deep dive here: Comprehensive Analysis of Testosterone Carrier Oils: Formulations, Clinical Implications, and Emerging Developments - Excel Male TRT Forum

More on caffeine : Molecular targets of caffeine in the central nervous system - Excel Male TRT Forum

Here’s a comparison of Caffeine, Paraxanthine, and Theophylline, focusing on their structure, effects, metabolism, and common uses: Comparison Table: Caffeine vs Paraxanthine vs Theophylline Feature Caffeine Paraxanthine Theophylline Chemical Name 1,3,7-trimethylxanthine...

Further reading: Building and maintaining muscle for longevity - Excel Male TRT Forum

More on treatments: How to Choose the Best BPH Treatment: UroLift, Rezūm, Aquablation & Expert Advice from Dr. Utsav Bansal - Excel Male TRT Forum

You may want to read this: Pros & Cons of 10 Surgery Types for Enlarged Prostate (BPH) - Which is Best for you!? - Excel Male TRT Forum

1. Why was the recent FDA hearing on menopause held, and what was its primary focus? The FDA held a long-overdue hearing on menopause due to a campaign by "Let's Talk Menopause" under the hashtag #unboxingmenopause. The primary focus was to address the black box warning on vaginal estrogen...

Briefing Document: The FDA Menopause Panel and the Fight for Accurate Women's Health Information Source: Excerpts from "What Really Happened at the FDA Menopause Panel - Fempower Health | A Women's Health Podcast" by Georgie Kovac. Date of FDA Hearing: July 17th (Year not specified, but context...

Very informative : Testosterone Therapy and Erythrocytosis - the most common dose-limiting effect of testosterone therapy - Excel Male TRT Forum

Researchers conducted a controlled trial with 63 healthy adults (average age ~42, roughly half women). Each person did two test sessions—once taking valsartan (a medication that blocks angiotensin II type 1 receptors, called AT₁) and once taking a placebo (calcium carbonate), in random order...

Here’s what I could piece together from publicly‑available sources: YearPublic milestoneDevelopment‑phase implication 2020International patent WO 2020/071912 published describing hCG‑loaded SynBiosys® microspheres and reporting only in‑vitro / animal data. Google PatentsPre‑clinical...